Syngeneic immune response to rat tracheal epithelial cells transformed in vitro by N-methyl-N-nitro-N-nitrosoguanidine. by Braslawsky, G. R. et al.
Br. J. Cancer (1981) 44, 247
SYNGENEIC IMMUNE RESPONSE TO RAT TRACHEAL
EPITHELIAL CELLS TRANSFORMED IN VITRO BY
N-METHYL-N-NITRO-N-NITROSOGUANIDINE
G. R. BRASLAWSKY*, V. STEELEt, S. J. KENNEL* AND P. NETTESHEIMt
From the *Biology Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830,
and tNational Institute of Environmental Health Sciences, Research Triangle Park,
North Carolina 27709, U.S.A.
Received 6 January 1981 Accepted 13 April 1981
Summary.-Two cell lines (2-10-1 and 8-10-2) derived by exposure of primary
tracheal explants to MNNG in vitro were not tumorigenic in syngeneic F-334 rats or
athymic BALB/c (nu/nu) mice at early passage, but became tumorigenic at late
passage. These cell lines are therefore suited to study the expression of neoantigens
during neoplastic development. Transplantation resistance to late-passage, tumori-
genic cells was induced in syngeneic rats using an immunization protocol of repeated
cell inoculation and tumour ablation. Spleen cells from such animals were reactive
in20h microcytotoxicity assays against neoplastic cell lines, but unreactive to normal
tracheal epithelial cells. Similarly, immune spleen cells co-cultivated in vitro for 6
days with irradiated neoplastic cell lines before assay for microcytotoxicity were
strongly reactive, whereas co-cultivation with normal epithelial cells did not
stimulate reactivity. Antibody to these neoplastic cell lines was demonstrated in sera
of tumour-resistant rats by an indirect radiolabelled-antibody binding test and by
indirect immunofluorescence. There was no significant binding to normal tracheal
epithelial cell outgrowths.
WITHIN THE LAST 'EW YEARS there
have been several reports on successful
induction ofin vitro neoplastic transforma-
tion of epithelial cells of skin (Colburn
et al., 1978), salivary gland (Knowles &
Franks, 1977), bladder (Hashimoto &
Kitagawa, 1975), liver (Borenfreund et
al., 1975) and trachea (Steele et al., 1977,
1979). We are interested in following the
course of antigen expression during early
stages of neoplastic development. The rat
tracheal explant system appears to be well
suited for such studies. Carcinogen expo-
sure of primary tracheal explants in vitro
leads to the appearance of transformed
cell lines (Steele et al., 1977, 1979). Early-
passage cells are often not tumorigenic,
but late-passage cell lines are. In order to
determine whether a change in antigen
expression during neoplastic development
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occurs, it was necessary to show that
tumorigenic tracheal epithelial cells trans-
formed in vitro express antigens not
present on untransformed cells, and to
find the means to quantitate such antigens.
While it has been established that tracheal
tumours induced by carcinogenic poly-
cyclic aromatic hydrocarbons in vivo
express antigens capable of stimulating
host responses (Jamasbi & Nettesheim,
1977a; Jamasbi et al., 1978) there have
been no reports on the immunogenicity
oftracheal epithelial cell lines transformed
in vitro. We report here that tumorigenic
cell lines derivedfrom rattracheal explants
exposed to N-methyl-N'-nitro-N-nitroso-
guanidine (MNNG) are immunogenic in
adult syngeneic rats. While both cellular
and humoral responses can be detected,
the antibody response will be most usefulG. R. BRASLAWSKY, V. STEELE, S. J. KENNEL AND P. NETTESHEIM
for studying the emergence of malignant
cell populations. Such studies are reported
below.
MATERIALS AND METHODS
Cell lines.-The two tracheal cell lines used
originated from tracheal explants which were
exposed for 6 h on Days 3 and 6 ofculture to
10 jtug MNNG/ml in Waymouth's MB 752/1
medium (Marchok etal., 1975, 1977). Explants
were obtained from 10-12-week-old female
Fischer-344 rats. After each carcinogen
exposure, cells were incubated in complete
medium (Waymouth's medium supplemented
with 10% FCS, insulin, hydrocortisone, non-
essential amino acids and fatty acids; see
Marchok et al., 1977). Primary cultures were
established from explants and stable epi-
thelial cell lines were obtained as described
previously (Steele et al., 1977). Cell lines were
passaged weekly by trypsin dissociation as
described by Steele et al. (1979).
Cell lines at various passage levels were
tested for tumorigenicity in either immuno-
suppressed syngeneic rats or athymic BALB/c
(nu/nu) mice. Rats were immunosuppressed
(thymectomized and whole-body X-irra-
diated) as described by Jamasbi &Nettesheim
(1977b), and were inoculated i.m. with 106
viable cells in 0-2 ml Hanks's balanced salt
solution (HBSS). Athymic BALB/c (nu/nu)
mice were inoculated s.c. with 106 cells in
0-1 ml HBSS. Animals were checked weekly
for tumour development.
The two cell lines, 8-10-2 and 2-10-1, were
used to immunize syngeneic rats and as cell
targets todemonstratehostimmuneresponses.
For these purposes, cultures were propa-
gated in complete Waymouth's media in
which syngeneic F-344 rat serum (supplemen-
ted to 2%) was substituted for FCS for at
least 2 passages before use.
Induction of transplantation immunity.-
F-344 female rats (10-12 weeks old) were
inoculated with tumorigenic passages of
either 8-10-2 or 2-10-1 cells. Tumour-bearing
legs were amputated when tumours were
3-5 cm in diameter (45-60 days for 2-10-1
and 30-50 days for 8-10-2). These animals
were rechallenged (s.c.) 14-21 days later and
subsequent tumour growth was surgically
removed. This procedure continued until the
animals rejected the challenge dose.
Microcytotoxicity assay.-The 20h micro-
cytotoxicity assay (Takasugi & Klein, 1970)
was used to measure spleen-cell cytotoxicity.
Epithelial cell lines served as target cells
and werepropagatedincompleteWaymouth's
media containing 2% isologous rat serum.
Target cells were trypsinized and 100 viable
cells in 0-1 ml were seeded in 96-well micro-
titre plates (Falcon No. 3034Microtestplates).
Only cultures with >90% viability wereused.
Nevertheless, plating efficiencies of tracheal
cell lines in rat serum varied between experi-
ments, though the number of cells attached
after 24 h within a particular experiment was
very consistent.
Spleen cells from rats which had rejected
a tumorigenic cell challenge were used as the
source of effector cells for microcytotoxicity
assays, and as responder cells for in vitro
sensitization experiments (Vose et al., 1977).
Rats which had resisted cell challenge were
re-inoculated with 106 cells, and their spleens
were removed 7 days later. Spleens from
non-immune F-344 rats served as controls.
Spleen cells were separated from erythrocytes
on 10ml Ficoll-Paque gradients (Pharmacia
Fine Chemicals). Lymphoid cells were col-
lected, washed x 3 and suspended in HBSS.
Cell suspensions showed >98% viability by
trypan-blue exclusion and contained 90%
nucleatped cells as determined by 0.1% crystal
violet staining.
Effector spleen cells were added to target
cells platedthe previous day. Knownnumbers
of effector cells were added to target cells in
0 1ml aliquots ofRPMI 1640 medium supple-
mented with 10% FCS. Plates were incubated
for 20 h at 37°C in 5% C02, washed x 3 with
HBSS to remove non-adherent cells, and the
remaining target cells fixed and stained with
crystal violet. After air drying the target cells
in each well were counted. Control cultures
consisted oftarget cells incubated with either
graded numbers of normal spleen cells or
medium alone.
Spleen cells from immune rats were also
co-cultivated invitrowith epithelial cell popu-
lations which had been lethally irradiated.
Cells were X-irradiated as monolayer cultures
in HBSS with 10 krad (250 rad/min). Irra-
diated cells were removed by trypsinization
and showed viability of >90%. Normal
lymphocytes were similarly irradiated but as
a single-cell suspension.
Both irradiated (2 x 105/ml) and responding
(2 x 106/ml) cell populations were suspended
in RPMI 1640 medium containing 10% FCS,
L-glutamine, antibiotics and 5 x 10-5M 2-
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mercaptoethanol (Cerottini et al., 1974). One
ml of each cell population was incubated in
12 x 75mm plastic tubes (Falcon No. 2054)
for 6 days in a humidified 37°C incubator. To
compensate for shifts in pH during incuba-
tion, the medium was buffered with 3-7 g/l
sodium bicarbonate and incubated in 800
C02-air.
After co-cultivation, cells from each group
were pooled, washed x 3 and the viability
was determined. Responder spleen cells were
used as effector cells in 20h microcytotoxicity
assays as described above. Controls consisted
of spleen cells incubated for 6 days with
irradiated lymphocytes from normal F-344
rats.
Antibody binding test (ABT).-Target cells
were grown as monolayer cultures on 10-5 x
22mm glass coverslips (Bellco Glass Co.).
Directly before use, monolayer coverslips
were chilled in cold HBSS, drained and
floated cell-side down for 1 h at 4°C on 0-1 ml
antiserum diluted in HBSS. Coverslips were
washed in 2 changes of chilled HBSS to
remove unbound antibody, and floated on
0-1 ml radiolabelled affinity-chromatography-
purified, rabbit antibody to rat IgG (PARG)
(Kennel & Feldman, 1976) for 1 h at 4°C
(0.5 ,ug antibody protein per reaction). PARG
was radiolabelled to specific activities of
5-10 x 105 ct/min/,ug with Na125I (New
England Nuclear) using Chloramine T
(McConahey & Dixon, 1966). Coverrlips were
washed in 3 changes of cold HBSS to remove
unbound label, and cell-bound radtioactivity
was determined with a Searle Model 1185
y-counter.
Controls consisted of monolayer cultures
incubated with: (a) HBSS followed bylabelled
PARG and (b) cell monolayers incubated
with diluted normal rat serum (NRS). In all
cases, nonspecific binding (NRS control) was
subtracted from experimental values before
estimating the amount of labelled antibody
protein specifically bound to target-cell
monolayers.
Fluorescent antibody tests.-Coverslips of
8-10-2 or 2-10-1 cells or normal cells from
primary tracheal outgrowths were prepared
as described above. The cells were washed
and incubated with normal or immune serum
as described above for the ABT, except that
fluorescein isothiocyanate-conjugated PARG
was substituted for radioiodinated PARG.
Cells were viewed on a Zeiss model micro-
scope with epi-illumination.
RESULTS
Development of tumorigenicity of tracheal
cell lines
As described previously (Steele et arl.,
1979) exposure ofprimary tracheal explhnt
cultures to MNNG in vitro produced stable
epithelial cell lines. Tumorigenicity of the
MNNG-induced tracheal cell lines was
determined by inoculation at various
passages of 106 cells into immunosup-
pressed F-334 rats or BALB/c (nu/nu)
mice (Table I). The time elapsing until
TABLE I.-Development of tumorigenicity
of MNNG-induced* tracheal epithelial
cell lines with successive in vitro cell
passages
Cell
line
8-10-2
Days
to
first
subeul-
turet
256
2-10-1 117
Passage Dayst
7 321
9 334
11 346
22 418
35 502
9 180
11 194
17 242
20 274
35 389
63 595
Tumorigenicityt
Iso- Xeno-
graft graft
0/4
0/4 0/2
4/4
- 4/4
5/5 --
0/2
0/4
0/4
0/4
4/4
4/4
4/4
4/4
* Tracheal organ cultures were exposed twice for
6 h to 10 jig/ml MNNG.
t Number of days after last carcinogen exposure.
t Determined by inoculation of 106 cells into
immunosuppressed Fischer-344 rats (isograft) or
athymic BALB/c (nu/nu) mice (xenograft).
the first subculture could be attempted
was 256 days for the 8-10-2 cell line and
117 days for the 2-10-1 cell line. Cell Line
8-10-2 became tumorigenic between Pas-
sages 9 and 11, and Cell Line 2-10-1
between Passages 20 and 35. No differen-
ces in tumorigenic potential have been
observed between the nude mouse xeno-
grafts and syngeneic rat transplantations.
I.m. inoculation of 2-10-1 cells (Passage
35) into immunosuppressed rats led to
rapid growth of highly malignant
squamous-cell carcinomas (Fig. 1). Inocu-
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FIG. 1.-Typical squamous carcinomas after inoculation of the 35th passage of the 2-10-1 cell line.
H.&E. x200.
FIG. 2.-Well-differentiated adenosquamous carcinoma with glandular structures filled with mucin-
like material, and typical of the carcinomas after inoculation of the 11th passage of the 8-10-2 cell
line. H. & E. x 200.
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lation of Passage 11 8-10-2 led to growth
of mixed adenosquamous carcinomas
(Fig. 2).
Induction of transplantation resistance to
malignant tracheal cell lines
To determine whether the malignant
phases of the two epithelial cell lines were
immunogenic, normal F-344 rats were
repeatedly challenged with viable cells,
as shown in Table II. Since cells grown in
TABLE II. Induction of transplantation
resistance in syngeneic rats
Exp. Cell No. of Tumour
No. line inocula take*
1 8-10-2 2 5/5
3 1/5
4 0/5
2 8-10-2 2 5/5
3 4/5
4 2/5
5 1/5
3 2-10-1 2 5/5
3 0/5
4 2-10-1 2 5/5
3 3/5
4 0/5
* Number of tumour-bearing rats/rats tested.
culture can adsorb antigenic determinants
from the serum in culture medium
(Embleton & Iype, 1978) all inoculations
were made with cells grown in 2%
isologous rat serum. Both 8-10-2 and2-10-1
cell lines induced transplantation resis-
tance (the ability of an animal to resist a
tumorigenic inoculation) in some or all
of the animals by the 3rd challenge. The
number ofresistant animals in each group
increased progressively with repeated cell
challenges.
Induction ofcell-mediated immunity
Spleen cells from rats showing trans-
plantation resistance to either 8-10-2 or
2-10-1 lines, or from unimmunized con-
trols, were tested for cytotoxic reactivity
against neoplastic cell lines or primary
tracheal outgrowths. As is shown in Table
III, 8-10-2-immune spleen cells caused a
significantly greater reduction in neo-
plastic target cells than non-immune
spleen cells. 2-10-1-immune spleen cells
showed moderate to strong cytotoxicity
for both target cell lines. While a linear
spleen-cell dose-response relationship
could not be demonstrated, in general,
lower numbers of immune cells produced
less cytotoxicity.
Primary tracheal outgrowths which
cannot be propagated in vitro have very
low plating efficiencies when trypsinized
and used as cell targets (Table 111, Exp.
4). However, there was negligible cyto-
toxicity of 8-10-2-immune spleen cells
towards these untransformed cell targets,
even at higher effector:target cell ratios
(30,000 effector spleen cells per well).
In order to test more fully for the
presence of antigen-bearing cells among
normal or transformed epithelial cells
(Engers & MacDonald, 1976) immune
spleen cells were co-cultivated for 6 days
in vitro with primary tracheal-outgrowth
cultures or neoplastic epithelial cell lines
before 20h microcytotoxicity testing. As
shown in Table IV, significant reactivity
for the immunizing target cell was ob-
tained when immune spleen cells were
co-cultivated with either of the neoplastic
cell lines. No cytotoxicity of immune
spleen cells for neoplastic target cells was
detected after co-cultivation with normal
trachealoutgrowths. Residual cytotoxicity
ofimmune spleen cells was also lost during
6-day co-cultivation with irradiated lym-
phocytes, indicating that antigen-bearing
cells must be present to maintain the
cytotoxic lymphocytes. No significant
differences were detected between target-
cell numbers in buffer control and normal-
lymphocyte control, with one exception,
where an increase in number of target
cells (expressed as a negative response)
was observed (Table IV).
Detection of circulating antibody
Sera obtained from immune rats were
first tested for antibody activity against
8-10-2 and 2-10-1 cell lines by the ABT.
Fig. 3 compares binding of sera from
2-10-1- or 8-10-2-immune rats to 2-10-1
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TABLE III.-Microcytotoxicity assay demonstrating reactivity ofspleen cellsfrom immune
rats to epithelial cell lines 2-10-1 and 8-10-2
Spleen cells/well
15,000 7500 3700
.-'A
Spleen-cell
Expt sourcet
1 8-10-2-immune
Normal
2 8-10-2-immune
Normal
3 2-10-1-immune
Normal
4 2-10-1-immune
Normal
Target Cells/
cells well:
8-10-2 76+ 4
2-10-1 67+ 7
8-10-2 124+3
2-10-1 91+ 14
8-10-2 23+ 2
2-10-1 20+ 2
Normal
outgrowthttl6 ± 4
8-10-2 37 +2
2-10-1 27+5
Normal
outgrowth 18+ 2
2-10-1 68+ 7
2-10-1 106+ 11
2-10-1 119 + 8
8-10-2 42+ 2
2-10-1 236+ 9
8-10-2 117+ 6
% Cells/
Red.§ well
39** 89+ 6
26* 59+13
111+ 11
85+ 3
38** 27+ 2
26* 18+4
11 18+3
33+5
25+4
17+2
36** 59+ 13
114+ 5
50** 138+ 12
64** 45+2
227 + 10
100+ 9
% Cells/
Red. well
20** 95+7
30** 77 + 6
124+12
114+5
18* 29 + 2
28* 23+ 2
-6 22+3
37+3
34 + 2
21+ 2
48** 77+6
84+3
39** 145+13
55** 47+5
230+ 10
114+ 4
% Cells/
Red. well
25** 99+ 9
32** 109+5
117+5
106+11
22* 30+ 2
32** 33+ 2
-5 ND
35+2
32+3
ND
8 109+5
80 + 6
37** 180 + 9
57** 74+ 5
228+ 12
111+ 7
t Spleen cells originated from syngeneic rats resistant to Cell Lines 8-10-2 or 2-10-1 or from normal rats.
There was no significant difference in number oftarget cells surviving, between wells without spleen cells and
those incubated with normal spleen cells.
t Average number of cells surviving per well + s.e.
§ Decrease in target-cell number after exposure to immune spleen cells compared to those exposed to
normal spleen cells. *P < 0O05 or **P < 0.01 by t test.
tt From untreated F-344 tracheal explants.
ND=Not done.
or 8-10-2 cell monolayers, respectively.
Normal F-344 rat serum was used at
appropriate dilutions to determine non-
specific binding, and these values (never
> 15 ng) were subtracted from experi-
mental results. Antibody binding is easily
detected even at 1/1000 dilutions in sera
from these immune rats.
The specificity of antibody binding was
determined by absorption ofimmune sera.
Antibody binding of anti-2-10-1 serum
(diluted 1: 80) was compared to binding
after absorption with either normal lung
homogenates or tumour homogenates
from 2-10-1 cells propagated in vivo (Fig.
4A). Absorption with normal-lung homo-
genates did not significantly reduce anti-
2-10-1 activity for 2-10-1 monolayers. In
contrast, absorption of 2-10-1-immune
serum with 2-10-1 cell homogenates re-
moved 94% of the binding activity.
Analogous results were obtained with
8-10-2-immune serum (Fig. 4B). The
ability of homologous tumour-cell absorp-
tions to remove antibody activity of
immune sera provided strong evidence
that binding activity of such antisera
were not directed against foetal calf serum
or other in vitro components.
Cross-reactivity between the two malig-
nant cell lines was demonstrated by serial
absorptions of serum obtained from trans-
plantation-resistant rats. Fig. 5A shows
the residual binding activity of anti-
2-10-1 serum on 2-10-1 cell monolayers
after absorption with normal tissue or
tumour-cell homogenates. Absorptionwith
normal-tissue homogenates removed less
than 15% ofthe original antibody activity,
whereas 82% of the original antibody
activity was removed by 3 absorptions
with 8-10-2 tumour homogenates. Two
absorptions using homologous 2-10-1
tumour homogenates removed >98% of
30,000
Red.
15*
-3
15
-3
-36
21**
33**
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TABLE IV.-Microcytotoxicity assay of spleen cells from immune rats, after 6-day
co-cultivation in vitro with lethally irradiated stimulating cells, to epithelial Cell Lines
2-10-1 and 8-10-2
Spleen cells/well
Target Responder
cell spleen cell
8-10-2 8-10-2-immune
Buffertt
8-10-2 8-10-2-immune
Buffer
2-10-1 2-10-1-immune
Buffer
X-irradiated
stimulating
cell
8-10-2
2-10-1
Normal
outgrowths
Lymphocytest
8-10-2
2-10-1
Normal
outgrowths
Lymphocytes
2-10-1
8-10-2
Normal
outgrowths
Lymphocytes
30,000
Cells/
welit
31+5
40+2
55+9
49+9
53+5
43 + 3
55 + 3
76+7
ND
84 + 5
ND
ND
ND
ND
ND
Red.§
41**
24*
15,000
c-
Cells %
well Red.
38+5 37**
50+8 18*
7500
Cells/ %
well Red.
54+6 IS*
46+ 3 30*
-4 66+9 8 66+6
8 54+10 11 45+2
61+5 66+9
49** 50+ 6 44** ND
34** 67 + 8 25** ND
9 86+5 3 ND
85+8 4 ND
89+7 ND
39+7 42** 31+1
43+ 10 36** 25+5
63+10 6 ND
90+5 -34 85+6
67+7 67+11
0
32*
54**
61**
-24
t Normal F-344 rat lymphocytes.
I Average number of target cells per well + s.e.
§ Percentage cell reduction of target cells exposed to spleen cells co-cultivated with irradiated cell popu-
lations as compared to target cells incubated for 6 days in buffer. *P < 005 or **P < 0-01 (t test).
tt TargetIcells incubated without spleen cells or with spleen cells co-cultivated with normal rat lympho-
cytes.:ND =Not done.
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FIG. 3.-Antibody binding test (ABT) of
serum from F-344 rats resistant to tumori-
genic 8-10-2 or 2-10-1 cell challenge.
0-0, reactivity of 2-10-1 immune serum
for cultured 2-10-1 cells. *-*, reactivity
of 8-10-2 immune serum for cultured 8-10-2
cells. Nonspecific binding was determined
for each serum dilution by substituting
normal rat serum for immune serum, and
subtracted from experimental values.
the antibody activity. Analogous results
were obtained in the reciprocal experiment
on anti-8-10-2 serum (Fig. 5B).
The ability of 8-10-2- or 2-10-1-immune
A. NS
P < 0.001
_ + -+
Normal 2-10-1
lung Cell line
B.
NS
P <0.001
-
+ - +
Normal 8-10-2
lung Cell line
FIG. 4.-Antibody binding of serum from
immune rats after absorption with normal
F-344 lung or tumour homogenates. A.
Serum from 2-10-1 immune rats was
diluted 1:80 and absorbed overnight with
either normal F-344 lung or with 2-10-1
tumour homogenates (+) and residual
antibody binding determined on 2-10-1 cell
monolayers by ABT. Binding results are
compared to an aliquot of antiserum
similarly treated but not absorbed (-).
B. Comparable tests with 8-10-2 cells.
t test for significance. NS =not significant.
rat antibody to bind specifically to neo-
plastic epithelial cell lines was also demon-
strated by indirect immunofluorescence.
I
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FIG. 5. Antibody binding of serum from
immune rats after serial absorptions with
normal F-344 rat tissue or tumour homo-
genates. Antisera were absorbed as de-
scribed in Fig.'4, separated from absorbing
homogenates by centrifugation (800 g for
10 min), and absorption repeated. A. Resi-
dual antibody activity on 2-10-1 cell mono-
layers after serial absorptions of 2-10-1-
immune serum. B. Residual antibody acti-
vity of absorbed anti-8-10-2 serum. Results
(% of control binding) represent binding
(ct/min) of the absorbed sample divided by
binding of a non-absorbed portion of the
same antiserum (x 100). Antisera were
absorbed with 2-10-1 (*), 8-10-2 (0),
normal rat brain (A), or liver (A) homo-
genates.
TABLE V.-Indirect immunoftuorescence
assay on antibody binding in immune-rat
sera for normal tracheal outgrowths or
neoplastic cell lines
Fluorescing cells*
Serum Serum
source If[rdilution 2-
Immune to
2-10-1 1/25
1/50
Normal rat 1/25
1/50
Immune to
8-10-2 1/25
1/50
Normal rat 1/25
1/50
* Cells were stained in
labelled anti-rat IgG dilute
1% BSA. Staining of cells M
as: - ( < 5% of the cells flu
the cells fluorescing).
Both anti-8-10-2 and a
positive on homologou
layers. In addition, 8
serum stained the sur
both neoplastic cell lii
50% of the neoplastic cells were stained,
whereas nonspecific fluorescence, as deter-
mined using NRS as controls, never
exceeded 5% of the cells. Under these
conditions, neither 8-10-2- nor 2-10-1-
immune rat sera demonstrated staining on
primary tracheal outgrowths.
Endogenous C-type virus activity
Cell lines used in these studies were
analysed for C-type viral gene products.
First, lysates of cells grown to confluency
were analysed for the major core protein
p30 using an interspecific radioimmuno-
assay (Strand & August, 1974; Kennel
& Tennant, 1979). This type of assay has
been shown to detect p3Os from rat, mouse,
and cat viruses (Strand & August, 1974;
Rasheed et al., 1976). Cell lysates from
confluent 100mm plates of 8-10-2 or 2-10-1
cells (t 5 x 106 cells) contained less than
5 ng of p30, which was 50-100 times less
than in virus-infected fibroblast cultures.
Secondly, putative virus pellets, concen-
trated 100-fold from culture fluids, were
analysed for reverse-transcriptase activity
by the method of Ross et al. (1971).
Neither 8-10-2 nor 2-10-1 cells demon-
strated enzyme levels above control (nor-
Primary mal fibroblast) values, whereas mouse
out- virus isolated from mouse fibroblasts and 10-1 8-10-2 growths baboon endogenous virus isolated from
+ ND - canine thymus cells had enzyme activities
+ ND - at least 20 times background.
- ND - Finally, syngeneic antisera to 2-10-1
- ND - and 8-10-2 cells were analysedfor antibody
+ + _ to gp7O by a sensitive antibody-binding-
+ + - capacity assay (Kennel, 1976). Of 8 sera
- - - tested, nonedemonstratedsignificantbind-
- - - ing of 1 ng of 1251 gp7O (< 2%), while
the cold with FITC- control antisera diluted 1000-fold bound
d 1:100 in HBSS with 82% of the labelled protein. Thus there
vas assessed subjectively was no detectable expression of C-type rrescing) or + (>5% of wsn eetbeepeso fCtp
viral genes in the rat tracheal-cell lines,
which are unlikely to be factors in the
,nti-2-10-1 sera were immune response of syngeneic animals.
is target-cell mono-
-10-2-immune anti-
face membranes of
nes (Table V) indi-
cating cross-reactive determinants. About
DISCUSSION
These studies have demonstrated that
tumorigenic passages of epithelial cell
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lines derived from rat tracheal explants
transformed in vitro by MNNG acquire
antigens capable of stimulating syngeneic
immunological responses. The two trans-
formed epithelial cell lines used in this
report were shown to be immunogenic by
induction of transplantation resistance
against tumorigenic inocula. Once trans-
plantation immunity was established, both
humoral and cell-mediated immune re-
sponses were evident. Previous studies
using in vivo carcinogen-induced pul-
monary adenomas of mice (Prehn, 1962;
Pasternak et al., 1966) and tracheal and
pulmonary squamous carcinomas of rats
(Jamasbi et al., 1978) have suggested that
respiratory-tract tumours are either poorly
immunogenic or incapable of eliciting any
type of syngeneic immune response. Im-
munogenicity of both in vitro carcinogen-
induced cell lines was weak, but demon-
strable, and is consistent with findings
from in vivo chemical induction.
Cell-mediated immune responses were
demonstrated with both primary effector
spleen cells (freshly harvested) or after
invitro co-cultivation witheitherneoplastic
cell line before microcytotoxicity assay
(secondary effector cells). Reactivity of
primary spleen effector cells was limited
to the neoplastic cell lines, and spleen-cell
reactivity against untransformed tracheal
outgrowths was not detected. Further-
more, reactivity of secondary effector
spleen cells for neoplastic cell targets was
maintained only by co-cultivation in vitro
with the neoplastic cell lines. Normal
tracheal outgrowths were incapable of
generating secondary effector cells in
vitro. These results support the conclusion
that immune spleen cells were reacting
with tumour-cell antigens not present in
the normal cell population
We have also demonstrated that sera
from immune rats contained antibody
directed at cell-surface antigens on neo-
plastic epithelial cell lines. Anti-tumour
antibody to rat respiratory-tract car-
cinomas induced in vivo (Jamasbi&Nettes-
heim, 1977a; Jamasbi et al., 1978) and to
human respiratory-tract carcinomas
(Gorny et al., 1979; Sofen & O'Toole,
1978) has been reported. In all cases, some
activity was also detected against normal
respiratory tissue. We were not able to
detect significant antibody activity against
normal respiratory-tract tissues by anti-
serum absorptions with lung homogenates.
Indirect immunofluorescence, which sup-
ported the findings ofthe ABT, also failed
to reveal any evidence ofantibody activity
for normal primary outgrowths.
The cross-reactivities of 8-10-2 and 2-
10-1 cell lines have not been evaluated
in vivo. However, common tumour-rejec-
tion antigens were found among several
benzo(a)pyrene or dimethylbenz(a)-
anthracene respiratory-tract carcinomas
induced in vivo in F-344 rats (Jamasbi &
Nettesheim, 1977b). The cross-reactivity
obtained in vitro using spleen cells from
tumour-immune animals appears to be
specific for the transformed cell lines, since
no reactivity was found for untransformed
tracheal epithelial cells. Furthermore, it is
unlikely that cross-reactivity between the
two epithelial cell lines was due to an
endogenous viral genome activated during
in vitro carcinogenesis (Rasheed, 1979). No
evidence of reverse-transcriptase activity
was found in these cell lines, and binding
of tumour-immune or tumour-bearing
sera to the gp7O macromolecule of murine
leukaemia virus was not demonstrable.
The presence of common antigens on
the surface of 8-10-2 and 2-10-1 cell lines
was also demonstrated by absorption
experiments. Absorption of2-10-1-immune
serum with 8-10-2 homogenates decreased
antibody binding to plateau levels ofabout
80% of the original activity. Quantitative
absorption tests with enhanced sensitivity
will have to be used to determine whether
specificities for a single tumour type are
also present in tumour-immune serum.
Rat tracheal-cell explants can be trans-
formed in vitro by carcinogens to generate
epithelial cell lines (Steele et al., 1977,
1979) which upon continued in vitro
propagation become tumorigenic. In this
report, we have used the syngeneic im-
mune response to identify cell-surface
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antigens on the tumorigenic cell popula-
tions. Such antigens detected on trans-
formed cell lines must have been acquired
as a result of neoplastic transformation,
since it was shown that untransformed cell
outgrowths lack detectable amounts of
these neo-antigens. It is at present not
known whether the appearance of neo-
antigens on chemically altered cells is an
essential feature ofoncogenesis, orwhether
it is merely a byproduct ofthe interaction
between the carcinogen and the cells.
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